Filing Details
- Accession Number:
- 0000921895-19-002384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 18:14:16
- Reporting Period:
- 2019-09-05
- Accepted Time:
- 2019-09-09 18:14:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1672828 | Lte Partners, Llc | C/O Lte Management, Llc 450 West 31St Street, 12Th Fl New York NY 10001 | No | No | Yes | Yes | |
1785671 | Lte Management, Llc | 450 West 31St Street 12Th Fl New York NY 10001 | No | No | Yes | Yes | |
1785674 | Melkonian Capital Management, Llc | 450 West 31St Street 12Th Fl New York NY 10001 | No | No | Yes | Yes | |
1785720 | Ryan Melkonian | C/O Melkonian Capital Management, Llc 450 West 31St Street, 12Th Fl New York NY 10001 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0013 Par Value | Acquisiton | 2019-09-05 | 43,520 | $4.62 | 1,928,520 | No | 4 | P | Direct | |
Common Stock, $0.0013 Par Value | Acquisiton | 2019-09-09 | 21,480 | $4.94 | 1,950,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- This Form 4 is filed jointly by LTE Partners, LLC ("LTE"), Melkonian Capital Management, LLC ("MCM"), LTE Management, LLC ("LTE Management"), and Ryan Melkonian (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
- Securities owned directly by LTE. Each of MCM, as the sole investment advisor to LTE, and LTE Management, as the sole manager of LTE, may be deemed tobeneficially own the securities owned directly by LTE. Mr. Melkonian, in his capacities as (i) the sole manager and majority member of LTE Management and (ii) the Chief Investment Officer, Management Member and majority owner of MCM, may also be deemed to beneficially own the securities owned directly by LTE.